Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
440.86%
Change (1 year)
Categories
Affimed (AFMD) Fails to deliver data
Key failure to deliver metrics for Affimed :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.01 M
- Last year FTD volume: $0.98 M
Failures to deliver for Affimed (AFMD) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Affimed (AFMD) - since 2021
Volume in USD (price x number of shares), data since 2021Affimed (AFMD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.01 M | -99.14% |
| 2023 | $1.64 M | 11.72% |
| 2022 | $1.47 M | -20.67% |
| 2021 | $1.85 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Repligen
RGEN | $8.5 M | $0.10 B | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.1 M | $0.98 M | 🇺🇸 USA |
 Agenus
AGEN | $3.33 M | $6.35 M | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | N/A | $0.02 M | 🇺🇸 USA |